In diet-induced NAFLD rodents, RANKL is upregulated in both circulation and liver [19], and blocking RANKL signaling in liver improves liver insulin resistance in HFD mice, suggesting that RANKL plays an important role in the pathogenesis of NAFLD [20]. This evidence concerns the gene TNFSF11 and metabolic dysfunction-associated steatotic liver disease.